The Enigmatic Protein Kinase C-eta

被引:17
作者
Basu, Alakananda [1 ]
机构
[1] Univ North Texas, Hlth Sci Ctr, Dept Microbiol Immunol & Genet, Ft Worth, TX 76107 USA
来源
CANCERS | 2019年 / 11卷 / 02期
关键词
protein kinase C; PKC eta; cell proliferation; differentiation; senescence; apoptosis; drug resistance; tumor promotion; tumor suppression; PKC-ETA; DOWN-REGULATION; NPKC-ETA; CHOLESTEROL SULFATE; CELLULAR SENESCENCE; UP-REGULATION; EXPRESSION; ISOFORM; CELLS; BREAST;
D O I
10.3390/cancers11020214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protein kinase C (PKC), a multi-gene family, plays critical roles in signal transduction and cell regulation. Protein kinase C-eta (PKC eta) is a unique member of the PKC family since its regulation is distinct from other PKC isozymes. PKC eta was shown to regulate cell proliferation, differentiation and cell death. It was also shown to contribute to chemoresistance in several cancers. PKC eta has been associated with several cancers, including renal cell carcinoma, glioblastoma, breast cancer, non-small cell lung cancer, and acute myeloid leukemia. However, mice lacking PKC eta were more susceptible to tumor formation in a two-stage carcinogenesis model, and it is downregulated in hepatocellular carcinoma. Thus, the role of PKC eta in cancer remains controversial. The purpose of this review article is to discuss how PKC eta regulates various cellular processes that may contribute to its contrasting roles in cancer.
引用
收藏
页数:12
相关论文
共 71 条
[1]  
Abu-Ghanem S, 2007, CANCER BIOL THER, V6, P1375
[2]   PKC-η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways [J].
Aeder, SE ;
Martin, PM ;
Soh, JW ;
Hussaini, IM .
ONCOGENE, 2004, 23 (56) :9062-9069
[3]   Overexpression of protein kinase C-η attenuates caspase activation and tumor necrosis factor-α-induced cell death [J].
Akkaraju, GR ;
Basu, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) :103-107
[4]   ISOLATION AND CHARACTERIZATION OF PKC-L, A NEW MEMBER OF THE PROTEIN-KINASE C-RELATED GENE FAMILY SPECIFICALLY EXPRESSED IN LUNG, SKIN, AND HEART [J].
BACHER, N ;
ZISMAN, Y ;
BERENT, E ;
LIVNEH, E .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) :126-133
[5]   THE POTENTIAL OF PROTEIN-KINASE-C AS A TARGET FOR ANTICANCER TREATMENT [J].
BASU, A .
PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) :257-280
[6]   The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-α [J].
Basu, A .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :105-111
[7]   Differential effects of protein kinase C-eta on apoptosis versus senescence [J].
Basu, Alakananda ;
Pal, Deepanwita ;
Blaydes, Rachel .
CELLULAR SIGNALLING, 2019, 55 :1-7
[8]   Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKCη with MDR1, MRP and LRP gene expression [J].
Beck, J ;
Bohnet, B ;
Brügger, D ;
Bader, P ;
Dietl, J ;
Scheper, RJ ;
Kandolf, R ;
Liu, C ;
Niethammer, D ;
Gekeler, V .
BRITISH JOURNAL OF CANCER, 1998, 77 (01) :87-91
[9]  
BLUMBERG PM, 1988, CANCER RES, V48, P1
[10]  
Brenner W, 2003, ANTICANCER RES, V23, P4001